Life Science REIT PLC Total Liabilities
Life Science REIT PLC total liabilities. Based on the latest financial reports, Life Science REIT PLC (LABS) has total liabilities worth GBX141.89 Million GBX (≈ $17.26K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See defensive interval ratio of Life Science REIT PLC to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Life Science REIT PLC (2021–2024)
Total liabilities of Life Science REIT PLC from 2021 to 2024. This chart illustrates how Life Science REIT PLC's total liabilities have evolved over time, based on quarterly financial data. Explore Life Science REIT PLC long-term investment intensity to see how much of total assets are deployed in long-term investments.
Life Science REIT PLC Competitors by Total Liabilities
The table below lists competitors of Life Science REIT PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Reach PLC
LSE:RCH
|
UK | GBX500.60 Million |
|
Fintech Chain Ltd
AU:FTC
|
Australia | AU$54.97 Million |
|
Hedera Group publ AB
ST:HEGR
|
Sweden | Skr122.20 Million |
|
Genprex Inc
NASDAQ:GNPX
|
USA | $2.34 Million |
|
Middlefield Canadian Income PCC - Middlefield Canadian Income - GBP PC
LSE:MCT
|
UK | GBX28.28 Million |
|
Monarca Minerals Inc
V:MMN
|
Canada | CA$6.00 Million |
|
Teneo AI AB
ST:TENEO
|
USA | Skr347.20 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Life Science REIT PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see LABS asset base.
Liquidity & Leverage Metrics
Life Science REIT PLC Total Liabilities Ratios Explained
Life Science REIT PLC total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.61 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Life Science REIT PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Life Science REIT PLC (2021–2024)
The table below shows the annual total liabilities of Life Science REIT PLC from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | GBX138.42 Million ≈ $16.84K |
+9.03% |
| 2023-12-31 | GBX126.96 Million ≈ $15.45K |
-1.10% |
| 2022-12-31 | GBX128.37 Million ≈ $15.62K |
+1086.45% |
| 2021-12-31 | GBX10.82 Million ≈ $1.32K |
-- |
About Life Science REIT PLC
Life Science REIT plc is a specialist property business focused on the UK's growing life science sector. The Company's portfolio of assets is located across the Golden Triangle of research and development hubs in Oxford, Cambridge and London's Knowledge Quarter. Life Science REIT trades on the Main Market of the London Stock Exchange under the ticker LABS.